Notice2022-02401
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 4, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 24 (Friday, February 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6559-6560]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02401]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0800]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Focus Group Testing to Effectively Plan and
Tailor Cancer Prevention and Control Communications Campaigns'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on July 26, 2021 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Focus Group Testing to Effectively Plan and Tailor Cancer
Prevention and Control Communications Campaigns (OMB Control No. 0920-
0800, Exp. 10/31/2021)--Reinstatement with Change--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the CDC's Division of Cancer Prevention and Control
(DCPC) is to reduce the burden of cancer in the United States through
cancer prevention, reduction of risk, early detection, and improved
quality of life
[[Page 6560]]
for cancer survivors. Toward this end, the DCPC supports the scientific
development and implementation of various health communication
campaigns with an emphasis on specific cancer burdens.
This process requires testing of messages, concepts, and materials
prior to their final development and dissemination, as described in the
second step of the health communication process. The health
communication process is a scientific model developed by the U.S.
Department of Health and Human Services' National Cancer Institute to
guide sound campaign development. The communication literature supports
various data collection methods to conduct credible formative, concept,
message, and materials testing. This process ensures that the public
clearly understands cancer-specific information and concepts, are
motivated to take the desired action, and do not react negatively to
the messages. CDC was previously approved to collect information needed
to plan and tailor cancer communication campaigns (OMB Control No.
0920-0800, Exp. 10/31/2021), and seeks OMB approval to revise the
existing generic clearance to include another cancer-related
communications campaign, expand the modes of data collection to include
online focus groups and in-depth interviews (in-person, phone, and
online), and to focus on respondents from the general public.
Information collection will involve discussions to assess numerous
qualitative dimensions of cancer prevention and control messages,
including but not limited to, cancer knowledge, attitudes, beliefs,
behavioral intentions, information needs and sources, and compliance
with cancer screening as recommended by the United States Preventive
Services Task Force. Insights gained from these discussions will assist
in the development and/or refinement of future campaign messages and
materials. Communication campaigns and messages will vary according to
the type of cancer and the qualitative dimensions of the message
described above.
A separate information collection request will be submitted to OMB
for approval of each discussion activity. The request will describe the
purpose of the activity and include the customized information
collection instruments. OMB approval is requested for three years. CDC
requests OMB approval for an estimated 1,680 annual burden hours.
Participation is voluntary and there are no costs to respondents except
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
General Public........................ Screening Form.......... 1,600 1 3/60
General Public........................ Discussion Guide........ 800 1 2
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-02401 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on February 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.